Enzymatic evaluation of chromenone derivatives from Flemingia philippinensis as viral neuraminidase (H3N2) inhibitors
- Authors
- Lee, Yong Hyun; Wang, Yan; Kim, Jeong Yoon; Lee, Gi Hwan; Kim, Jeong Ho; Shah, Abdul Bari; Park, Ki Hun
- Issue Date
- Dec-2023
- Publisher
- Elsevier BV
- Keywords
- Chromenone derivatives; Competitive inhibitor; Flemingia philippinensis; Influenza A viral neuraminidase H3N2; Noncompetitive inhibitors
- Citation
- Journal of Molecular Structure, v.1293
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Molecular Structure
- Volume
- 1293
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/67515
- DOI
- 10.1016/j.molstruc.2023.136243
- ISSN
- 0022-2860
1872-8014
- Abstract
- The chromenones (1–6) from F. philippinensis displayed significant inhibition against the viral neuraminidase of H3N2. All the target chromenones including the new compound 5 have a triketone skeleton consisting of 2-acetyl-1,3-cyclohexanedione, which provides a being stable structure as exocyclic keto and enol form itself. The most potent inhibitor was identified as chromenone 1 (IC50 = 4.6 µM), but a subtle change in the functionality markedly affected the inhibitory potency (IC50 = 4.6 ∼ 28.5 µM) and mode. In particular, chromenones (1 and 4) with the exocyclic enol form exhibited the competitive mode, whereas the keto forms (2, 3, 5, and 6) were noncompetitive. The competitive inhibitor, chromenone 1, was proved to interact in a reversible simple slow-binding mode, according to the respective parameters: Kiapp = 2.38 µM, k3 = 0.0013 µM−1min−1, and k4 = 0.0031 min−1. The binding interactions of the competitive (1 and 4) and noncompetitive (2 and 3) inhibitors at the catalytic and allosteric sites, respectively, were predicted by the molecular docking method. © 2023 Elsevier B.V.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 자연과학대학 > Department of Pharmaceutical Engineering > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.